Decision Support for Lower Respiratory Infections in Children
(ROADS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial focuses on reducing inappropriate antibiotic use in children with lower respiratory tract infections (LRTI) such as pneumonia or bronchiolitis. The study tests two new tools, ED Clinical Decision Support (CDS-ED) and Transitions Clinical Decision Support (CDS-Tr), designed to assist doctors in emergency departments and hospitals in making informed decisions about antibiotic use. Researchers compare these tools against usual care to evaluate their effectiveness. Children visiting the emergency room or admitted to the hospital with symptoms like a cough or shortness of breath may be suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity to contribute to important research that could enhance antibiotic use in children.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on reducing inappropriate antibiotic use for certain infections in children.
What prior data suggests that these clinical decision support tools are safe for use in pediatric emergency and inpatient settings?
Research has shown that clinical decision support (CDS) systems can help reduce unnecessary antibiotic use for respiratory infections. This is important because antibiotics can cause side effects, especially when not needed. CDS technology is generally well-accepted because it aids doctors in making better decisions rather than introducing a new drug or treatment.
Studies on similar CDS tools have demonstrated their effectiveness in hospitals. They help medical staff adhere more closely to guidelines, resulting in fewer unnecessary antibiotics. This enhances safety by reducing the risk of antibiotic side effects. While no direct human trial data exists for this specific CDS tool, similar tools have proven to be safe.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the potential of clinical decision support tools to improve care for children with lower respiratory infections. Unlike standard treatments that rely solely on the clinician's judgment and experience, these tools provide real-time, evidence-based guidance tailored to specific clinical settings. The ED Clinical Decision Support (CDS-ED) and Transitions Clinical Decision Support (CDS-Tr) tools aim to enhance decision-making in emergency and inpatient settings, respectively. By integrating these tools, the study hopes to optimize treatment plans, improve patient outcomes, and potentially streamline healthcare processes.
What evidence suggests that these clinical decision support tools are effective for reducing inappropriate antibiotic use in pediatric lower respiratory infections?
Research has shown that clinical decision support (CDS) systems can significantly reduce unnecessary antibiotic prescriptions for respiratory infections. One study suggested that these tools help doctors use antibiotics more appropriately for respiratory tract infections. In this trial, emergency room doctors will use the CDS-ED tool to improve antibiotic decision-making. Meanwhile, hospital doctors will use the CDS-Tr tool to ensure treatments align with the latest guidelines. Both tools, part of separate treatment arms in this trial, aim to address the issue of overprescribing antibiotics, which can lead to unwanted side effects and antibiotic resistance. These interventions have shown promise in aligning treatments with recommended practices.13678
Who Is on the Research Team?
Derek J Williams, MD, MPH
Principal Investigator
Vanderbilt University Medical Center
Are You a Good Fit for This Trial?
This trial is for children visiting the emergency department (ED) with lower respiratory tract infections like pneumonia, bronchiolitis, or asthma-related infections. It aims to reduce unnecessary antibiotic use in these patients.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive clinical decision support interventions in the ED and hospital settings to reduce inappropriate antibiotic use
Follow-up
Participants are monitored for safety and effectiveness after treatment, including antibiotic exposure and clinical outcomes
Extension
Long-term monitoring of antibiotic use and clinical outcomes
What Are the Treatments Tested in This Trial?
Interventions
- ED Clinical Decision Support (CDS-ED)
- Transitions Clinical Decision Support (CDS-Tr)
Trial Overview
The study tests two electronic Clinical Decision Support systems: one used in the ED (CDS-ED), and another during hospital transitions (CDS-Tr). The goal is to see if they help doctors prescribe antibiotics appropriately compared to usual care.
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Active Control
The Transitions clinical decision support tool will be offered to inpatient/ICU providers in these enrolled encounters.
The ED clinical decision support tool will be offered to emergency department providers in these enrolled encounters.
No experimental decision support will be provided to the emergency medicine providers in encounters randomized to the control arm. All patients will receive usual care and treatment will not be restricted or altered in any way by the study.
No experimental decision support will be provided to the inpatient/ICU providers in encounters randomized to the control arm. All patients will receive usual care and treatment will not be restricted or altered in any way by the study.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanderbilt University Medical Center
Lead Sponsor
Agency for Healthcare Research and Quality (AHRQ)
Collaborator
University of California, San Francisco
Collaborator
Published Research Related to This Trial
Citations
1.
withpower.com
withpower.com/trial/decision-support-for-lower-respiratory-infections-in-children-ae881Decision Support for Lower Respiratory Infections in Children
Research shows that clinical decision support (CDS) systems can help reduce unnecessary antibiotic prescribing for acute respiratory infections and improve ...
Reducing Overuse of Antibiotics with Decision Support
Eliminating inappropriate antibiotic use in pediatric lower respiratory tract infections (LRTI) is the central focus of this research.
Electronic Clinical Decision Support Tools to Manage ...
Lower respiratory tract infections were the leading cause of death among children under 5 years and the fifth cause of death among adults over 69 years.
Cost Study of a Cluster Randomized Trial on a Clinical ...
This study aims to evaluate the impact of the decision rule on healthcare and societal costs, and to describe costs of children with suspected lower respiratory ...
Effectiveness of decision support tools on reducing ...
This study suggests that CDSs effectively reduce inappropriate antibiotic use for RTIs among physicians.
Antibiotic Clinical Decision Support for Pneumonia in the ED
EHR-based CDS has proven effective, although the magnitude of benefit varies widely. Few evaluations of CDS have been conducted in the pediatric ED.
7.
publications.aap.org
publications.aap.org/pediatrics/article/156/1/e2024069478/202108/Clinical-Decision-Support-for-Septic-Shock-in-theClinical Decision Support for Septic Shock in the ...
The CDS used models identifying children who did not yet have shock but were predicted to be at high risk based on electronic health record data ...
Prognostic Clinical Decision Support for Pneumonia in the ...
Hospitalizations rates for childhood pneumonia vary widely. Risk-based clinical decision support (CDS) interventions may reduce unwarranted variation.
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.